Quarterly report [Sections 13 or 15(d)]

Summary of Stock Option Activity (Details)

v3.26.3
Summary of Stock Option Activity (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2026
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]    
Number of Shares, Beginning Balance 100,360  
Weighted Average Exercise Price, Beginning Balance $ 24.66  
Weighted Average Grant Date Fair Value, Beginning $ 23.42  
Weighted Average Remaining Contractual Term (Years), Outstanding 9 years 10 days 9 years 1 month 24 days
Aggregate Intrinsic Value, Beginning Balance  
Number of Shares, Granted 687,500  
Weighted Average Exercise Price, Granted $ 4.98  
Weighted Average Grant Date Fair Value, Granted $ 3.82  
Weighted Average Remaining Contractual Term (Years), Granted 8 years 11 months 4 days  
Aggregate Intrinsic Value, Granted  
Number of Shares, Exercised  
Weighted Average Exercise Price, Exercised  
Weighted Average Grant Date Fair Value, Exercised  
Number of Shares, Forfeited (126,509)  
Weighted Average Exercise Price, Forfeited $ 15.27  
Weighted Average Grant Date Fair Value, Forfeited $ 13.86  
Weighted Average Remaining Contractual Term (Years), Forfeited 8 years 6 months 29 days  
Number of Shares, Canceled/Expired (50)  
Weighted Average Exercise Price, Canceled/Expired $ 4,980.00  
Weighted Average Grant Date Fair Value, Canceled/Expired $ 4,710.00  
Weighted Average Remaining Contractual Term (Years), Canceled/Expired 6 years 8 months 8 days  
Number of Shares, Ending Balance 661,301 100,360
Weighted Average Exercise Price, Ending Balance $ 5.62 $ 24.66
Weighted Average Grant Date Fair Value, Ending $ 4.52 $ 23.42
Aggregate Intrinsic Value, Ending Balance
Number of Shares, Exercisable 535,051  
Weighted Average Grant Date Fair Value, Exercisable $ 5.75  
Weighted Average Exercise Price, Exercisable $ 4.59  
Weighted Average Remaining Contractual Term (Years), Exercisable 9 years 1 month 17 days  
Aggregate Intrinsic Value, Exercisable